Late manifestations of Lyme borreliosis;Spätmanifestationen der Lyme-borreliose

Therapeutische Umschau

Volumn 62, Issue 11, 2005, Pages 745-749

  Rossi, Marco ^a  

^a Abteilung Infektiologie   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ACRODERMATITIS; ANAMNESIS; ANTIBIOTIC THERAPY; BORRELIA BURGDORFERI; CHRONIC DISEASE; CLINICAL FEATURE; CONVALESCENCE; HUMAN; LYME DISEASE; PERSISTENT INFECTION; PROGNOSIS; REVIEW; SEROLOGY; TIME;

ACRODERMATITIS; ANTI-BACTERIAL AGENTS; DISEASE PROGRESSION; HUMANS; LYME DISEASE; LYME NEUROBORRELIOSIS; MYOCARDITIS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; TIME FACTORS;

EID: 28144439603     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.62.11.745     Document Type: Review

References (23)

1. Steere AC. Lyme Disease. N Engl J Med 2001; 345: 115-25.
2. Singh SK, Girschick HJ. Molecular survival strategies of the Lyme disease spirochete Borrelia burgdorferi. The Lancet Infectious Disease 2004; 4: 575-83.
3. Kersten A, Pitschek C, Rauch S, Aberer E. Effects of Penicillin, Ceftriaxone, and Doxycycline on Morphology of Borrelia burgdorferi. Antimicrob Agents Chemother 1995; 39: 1127-33.
4. Kaiser R, Kölmel H, Pfister H, Rauer S. Neuroborreliose. Leitlinien der Deutschen Gesellschaft für Neurologie. 2002 (Abrufbar unter http://www.uni-duesseldorf.de/WWW/AWMF/11/030-071.htm
5. Jaulhac B, Chary-Valckenaere I, Sibilia J, Javier R, Pourel J. Detection of Borrelia burgdorferi by DNA amplification in synovial tissue samples from patients with Lyme arthritis. Arthritis and Rheumatism 1996; 39: 736-45.
6. Kalish R, Kaplan R, Taylor E, Jones-Woodward L, Workman K, AL S. Evaluation of Study Patients with Lyme Disease, 10-20-Year Follow-up. J Infect Dis 2001; 183: 453-60.
7. Renaud I, Cachin C, Gerster J. Good outcomes of Lyme arthritis in 24 patients in an endemic area of Switzerland. Joint Bone Spine 2004; 71: 39-43.
8. Schnarr S, Putschky N, Jendro M, Zeidler H, Wollenhaupt J. Chlamydia and Borrelia DNA in synovial fluid of patients with early undifferentiated oligoarthritis: results of a prospective study. Arthritis and Rheumatism 2001; 44: 2679-85.
9. Molloy P, Persing D, Berardi V. False-positive results of PCR testing for Lyme disease. Clin Infect Dis 2001; 33: 412-13.
10. Evison J, Aebi C, Francioli P, Péter O, Weber R. Abklärung und Therapie der Lyme-Borreliose bei Erwachsenen und Kindern: Empfehlungen der Schweizerischen Gesellschaft für Infektiologie. Schweiz. Ärztezeitung 2005; in press.
11. Aberer E, Breier F, Stanek G, Schmidt B. Success and failure in the treatment of Acrodermatitis Chronica Atrophicans. Infection 1996; 24: 85-7.
12. Stanek G, Strle F. Lyme Borreliosis. Lancet 2003; 362: 1639-47.
13. Mikkilä H, Seppäla I, Viljanen M, Peltomaa M, Karma A. The expanding clinical spectrum of ocular lyme borreliosis. Ophthalmology 2000; 107: 581-7.
14. Seltzer E, Gerber M, Cartter M, K, Shapiro E. Long-term outcomes of persons with Lyme Disease. JAMA 2000; 283: 609-16.
15. Nowakowski J. Long-term Follow-up of Patients with Culture-Confirmed Lyme Disease. Am J Med 2003; 115: 91-6.
16. Kaplan R, Trevino R, Johnson G, Levy L, Klempner M. Cognitive function in post-treatement Lyme disease. Do additional antibiotics help? Neurology 2003; 60: 1916-22.
17. Reid CM, Schoen RT, Evans J, Rosenberg JC, Horwitz RI. The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study. Ann Intern Med 1998; 128: 354-62.
18. Vrethem M, Hellblom L, Widlund M, Ahl M, Danielsson O, Ernerudh J, et al. Chronic symptoms are common in patients with neuroborreliosis - a questionnaire follow-up study. Acta Neurol Scand 2002; 106: 205-8.
19. Berglund J, Stjernberg L, Ornstein K, Tykesson-Joelsson K, Walter H. 5-y follow-up study of patients with neuroborreliosis. Scand J Infect Dis 2002; 34: 421-5.
20. Wormser G, Nadelman R, Dattwyler R, Dennis D, Luft B. Practice Guidelines for the treatment of Lyme Disease. Clin Infect Dis 2000; 31(Suppl 1): S1-S14.
21. Fahrer H, van der Linden S, Sauvain M, Gern L, Aeschlimann A. The prevalence and incidence of clinical and asymptomatic Lyme borreliosis in a population at risk. J Infect Dis 1991; 163: 305-10.
22. Coyle P, Schutzer S. Neurologic aspects of Lyme disease. Med Clin North Am 2002; 86: 261-84.
23. th ed: McGraw-Hill; 2005. p. 998.